Kids

• Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference

  

  - The company to mark new phase of growth at Bio Campus II with the opening of Plant 5 in April - Samsung Biologics to offer ADC services and invest in advanced development and manufacturing capabili

  01-15

  Details

• Deye's Micro Hybrid ESS: A New Era of Compact, Efficient Power

  

  Suitable for on-grid,off-grid and portable use 96.5% DC-AC conversion efficiency 1000W rated power AC charge/discharge

  01-14

  Details

• Ring in the Year of the Snake at The Ritz-Carlton, Bali

  

  Honoring the traditions and festivities of Lunar New Year at the beachfront resort in Nusa Dua BALI,Indonesia,Jan. 13,2025-- The Ritz-Carlton,Bali,a luxury beach resort in Sawangan,Nusa Dua is thrill

  01-14

  Details

• GWM HYDROGEN-FTXT Delivers 406 Hydrogen Fuel Cell Sanitation Vehicles

  

  BAODING,China,Jan. 13,2025-- On January 10th,the first batch of 406 hydrogen fuel cell sanitation vehicles equipped withGWM HYDROGEN-FTXT\'s hydrogen power system were officially delivered to customer

  01-14

  Details

• KONE to equip a five-star hotel and commercial complex in Sihanoukville, Cambodia

  

  SINGAPORE,Jan. 13,2025--KONE Corporation,a global leader in the elevator and escalator industry,has won an order to provide a suite of People Flow® solutions for the Peninsula Integrated Resort b

  01-14

  Details

• PROMISE Technology@Intersec Dubai 2025: AI-Driven Plugins & Storage Setups

  

  Highlights: streamlining AI video analytics,extensive VMS plugin ecosystem,and full compatibility across operating systems

  01-14

  Details

• O-RAN ALLIANCE Announces Its New Board of Directors for the Term 2024-2026

  

  O-RAN ALLIANCE Extended Board of Directors has been elected for the upcoming 2-year term Abdurazak Mudesir,Group CTO of Deutsche Telekom,was re-elected as Chair of the Board

  01-14

  Details

• The Industry's First Cloud-Free Disposable is Coming: NEXA ULTRA InvisaCloud Edition

  

  01-14

  Details

• Regor Releases Phase 2a Topline Results for RGT-075, an Oral Once-daily Small Molecule GLP-1R Agonist, and Begins Phase 2b Study in the US for the Treatment of Obesity

  

  Regor announced its 12-week single-dose Phase 2a trial results for RGT-075,a once-daily oral GLP-1RA,reporting 5% placebo-adjusted weight-loss with no plateau

  01-13

  Details

• HARD ROCK HOTEL PENANG MARKS 10 YEARS OF COMMUNITY SPIRIT WITH ROCK TO ROCK RUN 2025

  

  GEORGE TOWN,Malaysia,Jan. 13,2025-- Hard Rock HotelPenang proudly announces the return of its highly anticipated charity event,Rock to Rock Run,scheduled for 15 June 2025 at 6.00 am.

  01-13

  Details